For decades, snack brands like Lay’s chips have emphasized the craveability of their products, declaring “Betcha can’t eat just one” to customers across countless marketing campaigns. But a growing number of Americans are challenging the validity of this classic slogan thanks to appetite-controlling drugs like Ozempic and Mounjaro. These pharmaceutical brands are quickly becoming big hits with consumers who want to reduce their compulsive eating habits, especially frequent snacking. According to one user, her grocery bills dropped by 20 percent Continue reading →